Cooper Companies (NASDAQ:COO) Issues FY 2026 Earnings Guidance

Cooper Companies (NASDAQ:COO) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 4.450-4.600 for the period, compared to the consensus estimate of 4.390. The company issued revenue guidance of $4.3 billion-$4.3 billion, compared to the consensus revenue estimate of $4.3 billion. Cooper Companies also updated its Q1 2026 guidance to 1.020-1.040 EPS.

Wall Street Analyst Weigh In

Several research firms have recently commented on COO. Weiss Ratings reissued a “hold (c-)” rating on shares of Cooper Companies in a research note on Monday. Stifel Nicolaus decreased their price target on Cooper Companies from $90.00 to $85.00 and set a “buy” rating on the stock in a report on Thursday, August 28th. JPMorgan Chase & Co. dropped their price objective on Cooper Companies from $76.00 to $66.00 and set a “neutral” rating for the company in a report on Thursday, August 28th. Morgan Stanley set a $76.00 target price on shares of Cooper Companies and gave the company an “equal weight” rating in a research report on Thursday, August 28th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $94.00 target price on shares of Cooper Companies in a research note on Thursday, August 28th. One equities research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Cooper Companies has an average rating of “Moderate Buy” and an average target price of $84.77.

Cooper Companies Trading Up 1.4%

NASDAQ COO traded up $1.05 during trading on Thursday, reaching $77.03. 5,109,095 shares of the stock traded hands, compared to its average volume of 2,409,264. Cooper Companies has a fifty-two week low of $61.78 and a fifty-two week high of $104.47. The company has a quick ratio of 1.24, a current ratio of 2.12 and a debt-to-equity ratio of 0.29. The firm has a market cap of $15.31 billion, a price-to-earnings ratio of 37.95, a price-to-earnings-growth ratio of 1.90 and a beta of 1.05. The stock’s 50-day moving average price is $71.81 and its 200 day moving average price is $71.70.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.04. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The company had revenue of $1.07 billion during the quarter, compared to analyst estimates of $1.06 billion. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Analysts predict that Cooper Companies will post 3.98 EPS for the current year.

Cooper Companies declared that its board has initiated a share repurchase plan on Wednesday, September 17th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the medical device company to purchase up to 15.4% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s management believes its shares are undervalued.

Insiders Place Their Bets

In other Cooper Companies news, Director Lawrence Erik Kurzius purchased 2,000 shares of the company’s stock in a transaction dated Monday, September 29th. The shares were bought at an average price of $68.39 per share, with a total value of $136,780.00. Following the completion of the transaction, the director directly owned 5,777 shares in the company, valued at $395,089.03. This trade represents a 52.95% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Gerard H. Warner III acquired 1,450 shares of the business’s stock in a transaction dated Friday, September 5th. The shares were acquired at an average price of $69.23 per share, for a total transaction of $100,383.50. Following the acquisition, the chief operating officer directly owned 18,319 shares in the company, valued at $1,268,224.37. This represents a 8.60% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired 13,450 shares of company stock worth $921,064 over the last ninety days. 1.98% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Cooper Companies

Several large investors have recently made changes to their positions in COO. CYBER HORNET ETFs LLC acquired a new stake in shares of Cooper Companies during the second quarter worth $36,000. MUFG Securities EMEA plc bought a new position in Cooper Companies during the 2nd quarter worth about $42,000. IFP Advisors Inc raised its stake in shares of Cooper Companies by 2,647.8% in the 3rd quarter. IFP Advisors Inc now owns 632 shares of the medical device company’s stock valued at $43,000 after purchasing an additional 609 shares during the period. Johnson Financial Group Inc. acquired a new stake in shares of Cooper Companies in the 3rd quarter valued at about $59,000. Finally, Advisory Services Network LLC bought a new stake in shares of Cooper Companies in the third quarter valued at about $163,000. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.